Substituted pyrazolo[1,5-a]pyrimidines as PI4K inhibitors
US11649238B2 · kind B2 · utility
0Cited by
1References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 15, 2019 |
| Grant date | May 16, 2023 |
| Priority date | — |
| Expiry date | Apr 1, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to compounds of formula (I) which are inhibitors of kinase activity, pharmaceutical formulations containing the compounds and their uses in treating and preventing viral infections and disorders caused or exacerbated by the viral infection wherein R1, R2, R3, R4a, R4b, R4c, R5, W, X, Y and Z are defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.